i am on tirzepatide a Candidate for Tirzepatide? Why am I not losing

Energy production: Helps convert food into usable energy, reducing fatigue

1017 The ESC guidelines for the management of cardiovascular disease in patients with diabetes recommend GLP1-RAs in patients with T2D and ASCVD to reduce cardiovascular events

Beyond potential weight-related benefits, some users have reported mood improvements and enhanced liver function after receiving the injections

In this study, participants using semaglutide had a lower risk for CVD-related events when compared with placebo.38 These results build on prior evidence that GLP-1s not only support blood sugar and weight management but also offer significant cardiovascular protection in high-risk populations.39 A 2021 systematic review published in Diabetes & Metabolic Syndrome: Clinical Research & Reviews examined six studies involving over 182,000 adults with T2DM to evaluate the cardioprotective effects of GLP-1s (primarily liraglutide and exenatide) taken in conjunction with blood pressure and cholesterol lowering medications.40 The findings showed consistent improvements in cardiac function, including increased left ventricular ejection fraction40 and reduced heart chamber volume, along with weight loss and improved myocardial blood flow

Say goodbye to dull, uneven skin and hello to a vibrant, glowing complexion with Shiro Advanced Glutathione

Patients should provide a complete list of prescription medications, over-the-counter drugs, and supplements to their healthcare provider